Biotech Division of Greenland Mines Announces Issuance of Patent in Canada for the Klotho Gene Therapy Platform Technology for Alzheimer’s and AgingCHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- via IBN -- Greenland Mines Ltd (Nasdaq: GRML) ("Greenland Mines" or the "Company") today announced that Innovation, Science and Economic Development Canada has granted Patent No. CA3,005,398, titled "SECRETED SPLICING VARIANT OF MAMMAL KLOTHO AS A MEDICAMENT FOR COGNITION AND MEMORY” covering technology exclusively licensed for worldwide commercialization from researchers at Universitat Autònoma de Barcelona and collaborating institutions. The issued patent protects the use of a human gene therapy using a nucleic acid gene sequence encoding the RNA splice variant protein called secreted Klotho or “s-KL”. The patent includes 42 granted claims of s-KL and its utility in treating several neurodegenerative diseases using a genetic-based therapy.
Greenland Mines Announces Limited-Duration Stockholder Rights Plan Intended to Protect Shareholder ValueCHARLOTTE, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- via IBN – Greenland Mines Ltd (Nasdaq: GRML) (“Greenland Mines” or the “Company”) announces that its Board of Directors has approved the adoption of a limited-duration stockholder rights plan, effective July 22, 2026, to protect the interests of the Company and its stockholders.
Greenland Mines Reports 36–44% PdEq Grade Uplift and +31% Increase in Indicated PdEq Ounces at its Skaergaard Gold, Palladium, Platinum Project in First S-K 1300 Technical Report SummaryUpdated 2026 MRE reflects strong grade and contained-metal increases versus 2022 baseline; S-K 1300 conversion establishes U.S. regulatory foundation as Company advances toward Initial Assessment
Biotech Division of Greenland Mines Announces Australian Patent Grant for Klotho Gene Therapy Technology for Treatment of Neuromuscular DiseasesNEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- via IBN -- Greenland Mines Ltd (Nasdaq: GRML) ("Greenland Mines" or the "Company") today announced that IP Australia has granted Australian Patent No. 2023252508, entitled "Treatment of Neuromuscular Diseases via Gene Therapy that Expresses Klotho Protein," covering technology exclusively licensed by the Company's Biotech Division. The patented technology was invented by researchers at Universitat Autònoma de Barcelona and collaborating institutions.
Greenland Mines Adds World Class Magmatic Researchers and Greenland Specialists to 2026 Skaergaard Field CampaignCHARLOTTE, N.C., July 07, 2026 (GLOBE NEWSWIRE) -- via IBN -- Greenland Mines Ltd (“Greenland Mines” or the “Company”) (Nasdaq: GRML) is pleased to announce that Professor Wolfgang Maier and Associate Professor Kristoffer Szilas will join the Company’s 2026 field campaign at the Skaergaard precious and critical metals project in southeast Greenland as part of the geological exploration and development team.
